Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Short report

ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro

Authors: Jianfeng Dai, Wen Pan, Penghua Wang

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

Dengue virus (DENV) and West Nile virus (WNV), close siblings of the Flaviviridae family, are the causative agents of Dengue hemorraghic shock or West Nile meningoencephalitis respectively. Vaccines against these two flaviviruses are currently unavailable. Interferon- Stimulated Gene 15 (ISG15), encoding an ubiquitin-like protein, is significantly induced by type I interferons or viral infections. Its roles in viral infections, however, vary with viruses, being either anti- or pro-viral. The exact roles of ISG15 in DENV and WNV infections remain unknown. In the current study, we evaluated the relevancies of ISG15 to DENV and WNV infection of a mouse macrophage cell line RAW264.7.

Findings

Quantitative PCR showed that mouse Isg15 was dramatically induced in DENV or WNV- infected RAW264.7 cells compared with non-infected cells. Isg15 and two other Jak-Stat related genes, Socs1 and Socs3, were silenced using siRNA mediated RNA interference. The intracellular DENV and WNV loads, as determined by quantitative PCR, were significantly higher in Isg15 silenced cells than control cells. The expression levels of interferon beta 1 (Ifnb1) were increased significantly in Isg15, Socs1 or Socs3 siRNA treated cells. Further investigation indicated that protein modification by ISG15, so called ISGylation, was significantly enhanced in DENV-infected cells compared to that in non-infected cells.

Conclusions

These findings suggest that ISG15 plays an anti-DENV/WNV function via protein ISGylation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fernandez-Garcia MD, Mazzon M, Jacobs M, Amara A: Pathogenesis of flavivirus infections: using and abusing the host cell. Cell Host Microbe 2009, 5: 318-328. 10.1016/j.chom.2009.04.001CrossRefPubMed Fernandez-Garcia MD, Mazzon M, Jacobs M, Amara A: Pathogenesis of flavivirus infections: using and abusing the host cell. Cell Host Microbe 2009, 5: 318-328. 10.1016/j.chom.2009.04.001CrossRefPubMed
2.
go back to reference Murphy BR, Whitehead SS: Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 2011, 29: 587-619. 10.1146/annurev-immunol-031210-101315CrossRefPubMed Murphy BR, Whitehead SS: Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 2011, 29: 587-619. 10.1146/annurev-immunol-031210-101315CrossRefPubMed
4.
5.
6.
go back to reference Pitha-Rowe IF, Pitha PM: Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev 2007, 18: 409-417. 10.1016/j.cytogfr.2007.06.017PubMedCentralCrossRefPubMed Pitha-Rowe IF, Pitha PM: Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev 2007, 18: 409-417. 10.1016/j.cytogfr.2007.06.017PubMedCentralCrossRefPubMed
8.
go back to reference Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM: Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 2005, 102: 10200-10205. 10.1073/pnas.0504754102PubMedCentralCrossRefPubMed Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM: Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 2005, 102: 10200-10205. 10.1073/pnas.0504754102PubMedCentralCrossRefPubMed
9.
go back to reference Durfee LA, Huibregtse JM: Identification and Validation of ISG15 Target Proteins. Subcell Biochem 2010, 54: 228-237. 10.1007/978-1-4419-6676-6_18CrossRefPubMed Durfee LA, Huibregtse JM: Identification and Validation of ISG15 Target Proteins. Subcell Biochem 2010, 54: 228-237. 10.1007/978-1-4419-6676-6_18CrossRefPubMed
10.
go back to reference Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE: Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 2006, 26: 472-479. 10.1128/MCB.26.2.472-479.2006PubMedCentralCrossRefPubMed Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE: Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 2006, 26: 472-479. 10.1128/MCB.26.2.472-479.2006PubMedCentralCrossRefPubMed
11.
go back to reference Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP: ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005, 25: 6338-6345. 10.1128/MCB.25.15.6338-6345.2005PubMedCentralCrossRefPubMed Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP: ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005, 25: 6338-6345. 10.1128/MCB.25.15.6338-6345.2005PubMedCentralCrossRefPubMed
12.
go back to reference Okumura A, Pitha PM, Harty RN: ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci USA 2008, 105: 3974-3979. 10.1073/pnas.0710629105PubMedCentralCrossRefPubMed Okumura A, Pitha PM, Harty RN: ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci USA 2008, 105: 3974-3979. 10.1073/pnas.0710629105PubMedCentralCrossRefPubMed
13.
go back to reference Durfee LA, Lyon N, Seo K, Huibregtse JM: The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 2010, 38: 722-732. 10.1016/j.molcel.2010.05.002PubMedCentralCrossRefPubMed Durfee LA, Lyon N, Seo K, Huibregtse JM: The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 2010, 38: 722-732. 10.1016/j.molcel.2010.05.002PubMedCentralCrossRefPubMed
14.
go back to reference Kim MJ, Yoo JY: Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J Immunol 2010, 185: 4311-4318. 10.4049/jimmunol.1000098CrossRefPubMed Kim MJ, Yoo JY: Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J Immunol 2010, 185: 4311-4318. 10.4049/jimmunol.1000098CrossRefPubMed
15.
go back to reference Zhao C, Hsiang TY, Kuo RL, Krug RM: ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci USA 2010, 107: 2253-2258. 10.1073/pnas.0909144107PubMedCentralCrossRefPubMed Zhao C, Hsiang TY, Kuo RL, Krug RM: ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci USA 2010, 107: 2253-2258. 10.1073/pnas.0909144107PubMedCentralCrossRefPubMed
16.
go back to reference Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, et al.: IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci USA 2007, 104: 1371-1376. 10.1073/pnas.0607038104PubMedCentralCrossRefPubMed Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, et al.: IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci USA 2007, 104: 1371-1376. 10.1073/pnas.0607038104PubMedCentralCrossRefPubMed
17.
go back to reference Okumura A, Lu G, Pitha-Rowe I, Pitha PM: Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci USA 2006, 103: 1440-1445. 10.1073/pnas.0510518103PubMedCentralCrossRefPubMed Okumura A, Lu G, Pitha-Rowe I, Pitha PM: Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci USA 2006, 103: 1440-1445. 10.1073/pnas.0510518103PubMedCentralCrossRefPubMed
18.
go back to reference Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, Garcia-Sastre A, Zhang DE, Lenschow DJ: Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 2009, 83: 1147-1151. 10.1128/JVI.00105-08PubMedCentralCrossRefPubMed Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, Garcia-Sastre A, Zhang DE, Lenschow DJ: Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 2009, 83: 1147-1151. 10.1128/JVI.00105-08PubMedCentralCrossRefPubMed
19.
go back to reference Lu G, Reinert JT, Pitha-Rowe I, Okumura A, Kellum M, Knobeloch KP, Hassel B, Pitha PM: ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisy-le-grand) 2006, 52: 29-41. Lu G, Reinert JT, Pitha-Rowe I, Okumura A, Kellum M, Knobeloch KP, Hassel B, Pitha PM: ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisy-le-grand) 2006, 52: 29-41.
20.
go back to reference Hsiao NW, Chen JW, Yang TC, Orloff GM, Wu YY, Lai CH, Lan YC, Lin CW: ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells. Antiviral Res 2010, 85: 504-511. 10.1016/j.antiviral.2009.12.007CrossRefPubMed Hsiao NW, Chen JW, Yang TC, Orloff GM, Wu YY, Lai CH, Lan YC, Lin CW: ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells. Antiviral Res 2010, 85: 504-511. 10.1016/j.antiviral.2009.12.007CrossRefPubMed
21.
go back to reference Chen L, Sun J, Meng L, Heathcote J, Edwards AM, McGilvray ID: ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. J Gen Virol 2010, 91: 382-388. 10.1099/vir.0.015388-0CrossRefPubMed Chen L, Sun J, Meng L, Heathcote J, Edwards AM, McGilvray ID: ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. J Gen Virol 2010, 91: 382-388. 10.1099/vir.0.015388-0CrossRefPubMed
22.
go back to reference Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A, Nur EKA, Liu LF: Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006, 66: 921-928. 10.1158/0008-5472.CAN-05-1123CrossRefPubMed Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A, Nur EKA, Liu LF: Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006, 66: 921-928. 10.1158/0008-5472.CAN-05-1123CrossRefPubMed
23.
go back to reference Hamerman JA, Hayashi F, Schroeder LA, Gygi SP, Haas AL, Hampson L, Coughlin P, Aebersold R, Aderem A: Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol 2002, 168: 2415-2423.CrossRefPubMed Hamerman JA, Hayashi F, Schroeder LA, Gygi SP, Haas AL, Hampson L, Coughlin P, Aebersold R, Aderem A: Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol 2002, 168: 2415-2423.CrossRefPubMed
24.
go back to reference Kim MJ, Hwang SY, Imaizumi T, Yoo JY: Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 2008, 82: 1474-1483. 10.1128/JVI.01650-07PubMedCentralCrossRefPubMed Kim MJ, Hwang SY, Imaizumi T, Yoo JY: Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 2008, 82: 1474-1483. 10.1128/JVI.01650-07PubMedCentralCrossRefPubMed
25.
go back to reference Frias-Staheli N, Giannakopoulos NV, Kikkert M, Taylor SL, Bridgen A, Paragas J, Richt JA, Rowland RR, Schmaljohn CS, Lenschow DJ, et al.: Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2: 404-416. 10.1016/j.chom.2007.09.014PubMedCentralCrossRefPubMed Frias-Staheli N, Giannakopoulos NV, Kikkert M, Taylor SL, Bridgen A, Paragas J, Richt JA, Rowland RR, Schmaljohn CS, Lenschow DJ, et al.: Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2: 404-416. 10.1016/j.chom.2007.09.014PubMedCentralCrossRefPubMed
Metadata
Title
ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro
Authors
Jianfeng Dai
Wen Pan
Penghua Wang
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-468

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.